Physician profile
Robert J Bernstein
NPI 1932205119
$631.14
in general payments reported to CMS, 2019-2025
9 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.92 · 2021: $44.23 · 2022: $145 · 2023: $126 · 2024: $128 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $176.08 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.87 | 2019-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Biotronik INC. | $73.75 | 2023 | Orsiro Mission |
| Glaxosmithkline, LLC. | $62.37 | 2019-2021 | |
| Insmed, INC. | $43.97 | 2025 | Arikayce |
| Baxter Healthcare | $37.99 | 2022 | |
| Boston Scientific Corporation | $34.86 | 2022 | |
| Electromed, INC. | $32.57 | 2022 | |
| Gilead Sciences, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.